DK184587A - Tiolaktam-n-eddikesyrederivater, produktion og anvendelse deraf - Google Patents

Tiolaktam-n-eddikesyrederivater, produktion og anvendelse deraf

Info

Publication number
DK184587A
DK184587A DK184587A DK184587A DK184587A DK 184587 A DK184587 A DK 184587A DK 184587 A DK184587 A DK 184587A DK 184587 A DK184587 A DK 184587A DK 184587 A DK184587 A DK 184587A
Authority
DK
Denmark
Prior art keywords
tiolaktam
production
acetic acid
acid derivatives
derivatives
Prior art date
Application number
DK184587A
Other languages
Danish (da)
English (en)
Other versions
DK184587D0 (da
Inventor
Kanji Meguro
Hitoshi Ikeda
Yujiro Yamamoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK184587D0 publication Critical patent/DK184587D0/da
Publication of DK184587A publication Critical patent/DK184587A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK184587A 1986-04-17 1987-04-10 Tiolaktam-n-eddikesyrederivater, produktion og anvendelse deraf DK184587A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8929586 1986-04-17
JP14594186 1986-06-20

Publications (2)

Publication Number Publication Date
DK184587D0 DK184587D0 (da) 1987-04-10
DK184587A true DK184587A (da) 1987-10-18

Family

ID=26430721

Family Applications (1)

Application Number Title Priority Date Filing Date
DK184587A DK184587A (da) 1986-04-17 1987-04-10 Tiolaktam-n-eddikesyrederivater, produktion og anvendelse deraf

Country Status (19)

Country Link
US (1) US4771050A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0243018B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS63107970A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR870010024A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1020098C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR244674A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU602641B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1287629C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3765682D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK184587A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2022889B3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI89711C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3001210T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK108293A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU198699B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE60246B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO167916C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT84704B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU1538895A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2996475B2 (ja) * 1989-12-22 1999-12-27 サントリー株式会社 ベンズオキサジノン誘導体及びそれを有効成分として含有する除草剤
TW200402B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1990-08-13 1993-02-21 Senju Pharma Co
AU638154B2 (en) * 1990-10-04 1993-06-17 Suntory Limited Benzoxazine derivative and herbicide containing same as an active ingredient
IE914455A1 (en) * 1990-12-27 1992-07-01 Green Cross Corp 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof
US5496817A (en) * 1992-08-31 1996-03-05 Santen Pharmaceutical Co., Ltd. 3-oxo-1,4-benzothiazine derivatives
JP3126541B2 (ja) * 1993-03-26 2001-01-22 千寿製薬株式会社 ベンゾチアゾール誘導体、その製法及びその用途
WO1995013269A1 (fr) * 1993-11-12 1995-05-18 Santen Pharmaceutical Co., Ltd. Derive de 1,4-benzothiazine
GB9412925D0 (en) * 1994-06-28 1994-08-17 Scotia Holdings Plc Combination of aldose reductase inhibitors with gamma-linolenic (GLA) dihomogammalinolenic (DGLA) or arachidonic (AA) acids in the treatment of diabetic
GB2338235B (en) * 1997-04-15 2001-11-14 Csir Appetite suppressing plant extracts
GB2355657B (en) * 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
US6713477B1 (en) 2000-04-19 2004-03-30 Sumitomo Pharmaceuticals Company, Limited Hydroxamic acid derivatives
GB2363985B (en) * 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
KR20030059287A (ko) 2000-11-30 2003-07-07 화이자 프로덕츠 인코포레이티드 Ｇａｂａ 작용제 및 알도스 리덕타제 억제제의 혼합물
JP4856537B2 (ja) * 2004-03-02 2012-01-18 大日本住友製薬株式会社 ベンゾチアジン−３−オン化合物及びその製造中間体
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US20070197512A1 (en) * 2006-01-27 2007-08-23 Japan Tobacco Inc. Carboxylic Acid Compounds and Use Thereof
WO2007086504A1 (ja) * 2006-01-27 2007-08-02 Japan Tobacco Inc. カルボン酸化合物及びその用途
WO2008110551A1 (en) 2007-03-12 2008-09-18 Zadec Aps An anti-diabetic extract of rooibos
EP2848252A3 (en) 2007-03-23 2015-06-17 The Board of Regents of the University of Texas System Aldose reductase inhibitors for use in treating uveitis
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
WO2012088525A2 (en) 2010-12-23 2012-06-28 The Board Of Regents Of The University Of Texas System Methods for treating copd
US12090142B2 (en) 2018-02-22 2024-09-17 Board Of Regents, The University Of Texas System Combination therapy for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
US3923709A (en) * 1974-08-30 1975-12-02 Monsanto Co 3,4-Dihydro-3-oxo-2H-1,4-benzothiazines and benzoxazines
IE58312B1 (en) * 1984-05-18 1993-09-08 Union Pharma Scient Appl Heterocyclic derivatives, processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors

Also Published As

Publication number Publication date
AU602641B2 (en) 1990-10-18
CA1287629C (en) 1991-08-13
AU7073087A (en) 1987-10-22
IE60246B1 (en) 1994-06-15
US4771050A (en) 1988-09-13
EP0243018B1 (en) 1990-10-24
DK184587D0 (da) 1987-04-10
GR3001210T3 (en) 1992-07-30
CN87102891A (zh) 1987-11-04
NO871526D0 (no) 1987-04-10
KR870010024A (ko) 1987-11-30
AR244674A1 (es) 1993-11-30
NO167916B (no) 1991-09-16
PT84704B (pt) 1989-11-30
SU1538895A3 (ru) 1990-01-23
CN1020098C (zh) 1993-03-17
PT84704A (en) 1987-05-01
JPH034550B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-01-23
ES2022889B3 (es) 1991-12-16
NO871526L (no) 1987-10-19
NO167916C (no) 1991-12-27
FI89711B (fi) 1993-07-30
IE871012L (en) 1987-10-17
HUT45515A (en) 1988-07-28
FI871719A0 (fi) 1987-04-16
FI871719L (fi) 1987-10-18
FI89711C (fi) 1993-11-10
DE3765682D1 (de) 1990-11-29
HK108293A (en) 1993-10-22
EP0243018A1 (en) 1987-10-28
HU198699B (en) 1989-11-28
JPS63107970A (ja) 1988-05-12

Similar Documents

Publication Publication Date Title
DK184587D0 (da) Tiolaktam-n-eddikesyrederivater, produktion og anvendelse deraf
DK451887A (da) Aryloxycarboxylsyrederivater, deres fremstilling og anvendelse
FI875484A7 (fi) Fosfinsyraderivat.
DE3780329D1 (de) Chinoloncarbonsaeure-derivate und ihre herstellung.
EP0202589A3 (en) Ascorbic acid derivatives, production and use thereof
DK374289A (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
DK605489A (da) Beta-amino-boronsyre-derivater, deres fremstilling og anvendelse
DE3785603D1 (de) Produktion von epsilon-kaprolaktam.
DK686487A (da) 1h-imidazol-5-carboxylsyrederivater
DK101287A (da) 1h-imidazol-5-carboxylsyrederivater
DK131887A (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
NO883082L (no) Substituerte alkenkarboksylsyreamider og derivater.
DK655487D0 (da) Furanuronsyrederivater
DK525687A (da) Enzymholdigt praeparat, dets fremstilling og anvendelse
DK296687D0 (da) N-1h-tetrazol-5-yl-2-thiophen-carboxamider, n-1h-tetrazol-5-yl-2-pyrrol-carboxamider og n-1h-tetrazol-5-yl-2-furan-carboxamider
DK451786D0 (da) Transglucosidase, fremstilling og anvendelse deraf
DE3787160D1 (de) Delta-hydroxy-beta-lysin-Derivate und ihre Produktion.
DE3864841D1 (de) Carbonsaeure-derivate.
DK9588A (da) 2,1-benzothiazepin-2,2-dioxid-5-carboxylsyrederivater
ZA872628B (en) Thiolactam-n-acetic acid derivatives,their production and use
TR22461A (tr) Aluminyum fosfinat-amin katilma ueruenleri,ve bunlarin ueretimi ve kullanimi
ZA863421B (en) Ascorbic acid derivatives,production and use thereof
DK202986D0 (da) Permethrinsyre-(triazolyl-alkyl)-estere, deres fremstilling og anvendelse
IT1221507B (it) Acil-glicosidi fosforilati,loro pro duzione e loro impiego
ATE75228T1 (de) 1h-imidazol-5-carbonsaeurederivate.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment